Consent Decree News
Most Popular Consent Decree Story
Genzyme's new plant to boost Fabrazyme supply
Genzyme says that, barring validation and regulatory hiccups, it expects to begin providing Fabry disease sufferers with Fabrazyme produced at its new Framingham, MA, plant beginning the first Read more...
Latest Headlines
- January 30, 2012
- January 30, 2012
- January 26, 2012
- January 24, 2012
- January 18, 2012
- January 16, 2012
- January 9, 2012
- January 2, 2012
- December 30, 2011
- December 21, 2011
- December 12, 2011
- October 31, 2011
- October 3, 2011
- September 19, 2011
- September 19, 2011
- June 14, 2011
- March 14, 2011
- March 14, 2011
- January 20, 2011
- December 23, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
